KEGG   ORTHOLOGY: K04012
Entry
K04012                      KO                                     
Symbol
CR2, CD21
Name
complement receptor type 2
Pathway
map04610  Complement and coagulation cascades
map04640  Hematopoietic cell lineage
map04662  B cell receptor signaling pathway
map05169  Epstein-Barr virus infection
Disease
H00080  Systemic lupus erythematosus
H00088  Common variable immunodeficiency
Brite
KEGG Orthology (KO) [BR:ko00001]
 09150 Organismal Systems
  09151 Immune system
   04640 Hematopoietic cell lineage
    K04012  CR2, CD21; complement receptor type 2
   04610 Complement and coagulation cascades
    K04012  CR2, CD21; complement receptor type 2
   04662 B cell receptor signaling pathway
    K04012  CR2, CD21; complement receptor type 2
 09160 Human Diseases
  09172 Infectious disease: viral
   05169 Epstein-Barr virus infection
    K04012  CR2, CD21; complement receptor type 2
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04090 CD molecules
    K04012  CR2, CD21; complement receptor type 2
CD molecules [BR:ko04090]
 Proteins
  K04012  CD21, CR2; complement component (3d/Epstein Barr virus) receptor 2
Genes
HSA: 1380(CR2)
PPS: 100983119(CR2)
GGO: 101139118(CR2)
PON: 103890063(CR2)
NLE: 100587321(CR2)
HMH: 116457505(CR2)
MCC: 714202(CR2)
MCF: 102145559(CR2)
MTHB: 126949098
MNI: 105484877(CR2)
CSAB: 103230175(CR2)
CATY: 105576948(CR2)
PANU: 103878155(CR2)
TGE: 112631326(CR2)
MLEU: 105529635(CR2)
RRO: 104664178(CR2)
RBB: 108535125(CR2)
TFN: 117074329(CR2)
PTEH: 111522745(CR2)
CANG: 105508888(CR2)
CJC: 108587696(CR2)
SBQ: 101045483(CR2)
CIMI: 108302100(CR2)
CSYR: 103270786(CR2)
MMUR: 105868169
LCAT: 123626891(CR2)
PCOQ: 105805844(CR2)
MMU: 12902(Cr2)
MCAL: 110289952(Cr2)
MPAH: 110321620(Cr2)
RNO: 289395(Cr2)
MCOC: 116097050
ANU: 117716040
CGE: 100773072(Cr2)
MAUA: 101833542(Cr2)
PROB: 127223972(Cr2)
PLEU: 114687531(Cr2)
MORG: 121435805(Cr2)
MFOT: 126505312
AAMP: 119827208(Cr2)
NGI: 103727020
HGL: 101704987(Cr2)
CPOC: 101787675(Cr2)
CCAN: 109686661(Cr2)
DORD: 105986437(Cr2)
DSP: 122109126(Cr2)
PLOP: 125360217(Cr2)
NCAR: 124961794
MMMA: 107140594(Cr2)
OCU: 108178217
OPI: 101528116(CR2)
TUP: 106736072(CR2)
GVR: 103582723 103610902
CFA: 490269
CLUD: 112648316
VVP: 112910983(CR2)
VLG: 121492856(CR2)
NPO: 129505911
AML: 100482465(CR2)
UMR: 103657661
UAH: 113242610(CR2)
UAR: 123785654(CR2)
ELK: 111151001
MPUF: 101687991(CR2)
MNP: 132025560(CR2) 132025986
MLK: 131814396(CR2)
NVS: 122918733
ORO: 101379114(CR2)
EJU: 114221931(CR2)
ZCA: 113933202(CR2)
MLX: 118014260(CR2)
NSU: 110573896(CR2)
LWW: 102737455
FCA: 101094393(CR2)
PYU: 121022445(CR2)
PBG: 122475744(CR2)
PVIV: 125155670(CR2)
LRUF: 124510071
PTG: 102963617(CR2)
PPAD: 109255275(CR2)
PUC: 125925339
AJU: 106981813
HHV: 120230487(CR2)
BTA: 407126(CR2)
BOM: 102281632(CR2)
BBUB: 102389290(CR2)
BBIS: 104998843(CR2)
CHX: 102186615(CR2)
OAS: 443017(CR2)
BTAX: 128061220(CR2)
ODA: 120879923(CR2)
CCAD: 122452577(CR2)
MBEZ: 129551717(CR2)
CFR: 102510063(CR2)
CBAI: 105075416(CR2)
CDK: 105098600(CR2)
BACU: 102998901(CR2)
BMUS: 118884422(CR2)
LVE: 103079671(CR2)
OOR: 101269842(CR2)
DLE: 111184731(CR2)
PCAD: 102977150(CR2)
PSIU: 116760650(CR2)
NASI: 112403481(CR2)
ECB: 100057298
EPZ: 103556834(CR2)
EAI: 106842726
MYB: 102240721(CR2) 102255761
MYD: 102761318
MMYO: 118673476(CR2)
MLF: 102435658(CR2)
PKL: 118721264(CR2)
EFUS: 103304232 114229928
SHON: 118982573(CR2)
AJM: 119056821(CR2)
PDIC: 114512110 114512181(CR2)
PHAS: 123813408 123817877(CR2)
MMF: 118637139
PPAM: 129062055 129062464(CR2)
HAI: 109374503(CR2)
RFQ: 117015118(CR2)
PALE: 102883716(CR2)
PGIG: 120589495
PVP: 105309560(CR2)
RAY: 107497825(CR2) 107505212
TOD: 119234695
SARA: 101553017(CR2)
SETR: 126004300(CR2)
LAV: 111750709(CR2)
MDO: 100020467 100619118 103095206
GAS: 123245323
SHR: 100914918(CR2)
PCW: 110203606 110219631(CR2)
OAA: 100084581
NMEL: 110388364
TGU: 100223070
LSR: 110473441
SCAN: 103822400
PMOA: 120497637
FCH: 114018057
EGZ: 104131253
ACHC: 115335290
BREG: 104632038 104638086
ASN: 102374961 112548817
AMJ: 102574670
PSS: 112543738
CABI: 116832998
PVT: 110086564
PMUR: 107288378
TSR: 106555378
PGUT: 117664328
NSS: 113418085
EMC: 129329825
MUO: 115482058
LOA: LOAG_07630
MMER: 123531452 123532622
 » show all
Reference
PMID:2563370
  Authors
Fujisaku A, Harley JB, Frank MB, Gruner BA, Frazier B, Holers VM
  Title
Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
  Journal
J Biol Chem 264:2118-25 (1989)
  Sequence
[hsa:1380]
Reference
PMID:10741859
  Authors
Prodinger WM
  Title
Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.
  Journal
Immunol Res 20:187-94 (1999)
DOI:10.1007/BF02790402
Reference
PMID:7753047
  Authors
Barel M, Balbo M, Gauffre A, Frade R
  Title
Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein.
  Journal
Mol Immunol 32:389-97 (1995)
DOI:10.1016/0161-5890(95)00005-Y
  Sequence
[hsa:1380]

  All links  
Ontology (2)   
   KEGG BRITE (2)   
Pathway (8)   
   KEGG PATHWAY (8)   
Disease (2)   
   KEGG DISEASE (2)   
Gene (210)   
   KEGG GENES (170)   
   KEGG MGENES (7)   
   RefGene (24)   
   OC (9)   
Literature (3)   
   PubMed (3)   
All databases (225)   

Download RDF
DBGET integrated database retrieval system